1. Home
  2. ICD-10-PCS
  3. XW0DXJ5
  4. Share
  5. Feedback

ICD-10-PCS Code XW0DXJ5

Introduction of Apalutamide Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 5
“Introduce Apalutamide in Mouth/Phar, Extern, New Tech 5” for short

XW0DXJ5 is a valid billable ICD-10 procedure code for Introduction of Apalutamide Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 5. It is found in the 2024 version of the ICD-10 Procedure Coding System (PCS) and can be used in all HIPAA-covered transactions from Oct 01, 2023 - Sep 30, 2024.

Introduction involves:
Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.

External approach involves:
Procedures performed directly on the skin or mucous membrane and procedures performed indirectly by the application of external force through the skin or mucous membrane

Apalutamide Antineoplastic device includes:

  • ERLEADA(tm)

ICD-10-PCS code structure for XW0DXJ5 — See Table View

1: Section X New Technology
2: Body System W Anatomical Regions
3: Root Operation 0 Introduction
4: Body Part D Mouth and Pharynx
5: Approach X External
6: Device J Apalutamide Antineoplastic
7: Qualifier 5 New Technology Group 5

See also

  • The ICD-10-PCS Index of common procedure terms.
  • New Technology terms in the ICD-10-PCS Definitions table. These definitions may also provide additional explanation and/or examples within this section.
  • The ICD-10-PCS Device Aggregation Table containing entries that correlate a specific ICD-10-PCS device value with a general device value to be used in tables containing only general device values.